The REBYOTA Patient Assistance Program is only available for qualified patients enrolled in REBYOTA Connect.
Participation in the PAP is free. Ferring does not collect any fees from people seeking assistance through PAP.
Assistance is provided in the form of free product shipped to site of administration or reimbursement for the invoiced cost of the product if processed after product has been administered. If assistance is in the form of free product, REBYOTA must be secured at the site of administration until the qualified PAP patient’s treatment date, and the medicine must be provided only to the eligible patient at no charge of any kind for the product. If product administration occurs and patient was qualified for PAP, reimbursement for the invoiced cost of the product can occur for Healthcare Providers or Specialty Pharmacies after they have provided supporting documentation for the product cost only in addition to a completed Reimbursement Request form. The REBYOTA PAP only covers the cost of the product and not administration or other services.
Any medications supplied by Ferring as a result of enrollment in the PAP are for the use of the named patient only and will not be sold, traded, bartered, transferred, returned for credit, or submitted to any third party (such as Medicare, Medicaid, or other benefit provider) for reimbursement.
If REBYOTA is no longer medically necessary for a qualified patient’s treatment or if the patient’s insurance or financial status changes, this must be reported to REBYOTA Connect.
If patient authorization is signed, electronic verification of a patient’s financial status is available to help determine eligibility,
PAP beneficiaries with government insurance are eligible to obtain medication through the end of the calendar year. PAP beneficiaries with commercial insurance are eligible to obtain medication for up to 12 months.
Healthcare Providers may not submit claims or payment from this medication through an insurance plan of any kind. Patients may not seek true out-of-pocket (TrOOP) or other insurance credit for medication provided through the PAP.
If applicable, PAP recipients will have their health plans receive written notification.
Ferring may change or cancel the PAP at any time and Ferring reserves the right to terminate a patient’s enrollment in the PAP at any time.
If you were screened for additional financial assistance offerings through the REBYOTA Connect Program and were informed you do not qualify, please click here to file an appeal.